1Bagshaw SM, Morris G, Doig C J, et al. One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment[ J ]. Am J Kidney Dis, 2006,48 ( 3 ) :402-409.
3Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach [J]. Circulation, 2006, 113 ( 14): 1799-1806.
4Barrett B J, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium [J]. N Engl J Med, 2006,354(4) :379-386.
5Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology [ J ]. A JR Am J Roentgenol, 2003,181 (6) : 1463-1471.
6K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification [ J ]. Am J Kidney Dis, 2002,39 ( 2 Suppl 1 ) :S1-S266.
7McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy[ J]. Am J Cardiol,2006,98 (6A) :27k-36k.
8Lindsay J, Apple S, Pinnow EE, et al. Percutaneous coronary intervention- associated nephropathy foreshadows inncreased risk of late adverse events in patients with normal baseline serum creatinine [ J ]. Catheter Cardiovasc Interv,2003,59 ( 3 ) : 338 -343.
9Lindsay J, Canos DA, Apple S, et al. Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine [J]. Am J Cardiol,2004, 94(6) :786-789.
10Dangas G, lakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary intervenions in relation to chronic kidney disease and hemodynamic variables [ J ]. AmJ Eardiol,2005, 95 ( 1 ) : 13-19.
5Gupta R, Bimbaum Y, Uretsky BF. The renal patient with coronary artery disease. Current concepts and dilemmas[ J ]. Am Coil Cardiol,2004,44(7) : 1343-1353.
6American Diabates Association. Clinical practice recommendations 2002 [ J ]. Diabetes Care, 2002, 25 ( Suppl 1 ) : S1-S147.
7McCullough PA, Adam A, Becket CR, et al. Risk prediction of contrast-lnduced nephmpathy[ J]. Am J Cardiol,2006,98 (6A) : 27K-36K.
8Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary intervenions in relation to chronic kidney disease and hemodynamic variables [ J]. Am J Cardiol,2005,95 ( 1 ) : 13-19.
9Dussol B, Morange S, Loundoun A, et al. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients [ J ]. Nephrol Dial Transplant, 2006, 21 (8) :2120-2126.
10Barrett B J, Katzberg RW, Thomsen HS, et al. Contrast-induced nephropathy in patients with chronic kidnwy disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol [ J ]. Invest Radiol, 2006,41 (11) :815-821.
